# United States Commodity Index Funds Trust: financial statements, quarterly

USCI · NYSE · CIK 1479247 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/usci.md) · [Financials](/companies/usci/financials.md) · [Filings](/companies/usci/filings.md) · [Insiders](/companies/usci/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/usci/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2019 (2019-06-30) | Q3 FY2019 (2019-09-30) | Q4 FY2019 (2019-12-31) | Q1 FY2020 (2020-03-31) | Q2 FY2020 (2020-06-30) | Q3 FY2020 (2020-09-30) | Q4 FY2020 (2020-12-31) | Q1 FY2021 (2021-03-31) | Q2 FY2021 (2021-06-30) | Q3 FY2021 (2021-09-30) | Q4 FY2021 (2021-12-31) | Q1 FY2022 (2022-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [(19.2)](/filings/0001144204-19-038523.md) | [(11.0)](/filings/0001104659-19-061527.md) | [7.2 d](/filings/0001104659-21-029196.md) | [(54.7)](/filings/0001104659-20-058625.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [(20.4)](/filings/0001144204-19-038523.md) | [(11.8)](/filings/0001104659-19-061527.md) | [6.6 d](/filings/0001410578-22-000220.md) | [(55.1)](/filings/0001104659-21-062892.md) | [4.8 d](/filings/0001104659-21-101306.md) | [17.5 d](/filings/0001104659-21-134870.md) | [14.7 d](/filings/0001410578-22-000220.md) | [23.5](/filings/0001410578-22-001160.md) | [30.1 d](/filings/0001104659-21-101306.md) | [(11.6) d](/filings/0001104659-21-134870.md) | [33.4 d](/filings/0001410578-22-000220.md) | [78.7](/filings/0001410578-22-001160.md) |

- Revenue: us-gaap:Revenues
- Operating income: not reported
- Net income: us-gaap:NetIncomeLoss

## Balance sheet

| Line item | Unit | Q2 FY2019 (2019-06-30) | Q3 FY2019 (2019-09-30) | FY2019 (2019-12-31) | Q1 FY2020 (2020-03-31) | Q2 FY2020 (2020-06-30) | Q3 FY2020 (2020-09-30) | FY2020 (2020-12-31) | Q1 FY2021 (2021-03-31) | Q2 FY2021 (2021-06-30) | Q3 FY2021 (2021-09-30) | FY2021 (2021-12-31) | Q1 FY2022 (2022-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [332](/filings/0001104659-20-091993.md) | [235](/filings/0001104659-20-122361.md) | [170](/filings/0001410578-22-000220.md) | [110](/filings/0001104659-21-062892.md) | [129](/filings/0001104659-21-101306.md) | [125](/filings/0001104659-21-134870.md) | [166](/filings/0001410578-22-000220.md) | [340](/filings/0001410578-22-001160.md) | [497](/filings/0001104659-21-101306.md) | [467](/filings/0001104659-21-134870.md) | [431](/filings/0001410578-22-000220.md) | [575](/filings/0001410578-22-001160.md) |
| Total assets | $m | [361](/filings/0001144204-19-038523.md) | [259](/filings/0001104659-19-061527.md) | [200](/filings/0001104659-20-058625.md) | [129](/filings/0001104659-20-058625.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total liabilities | $m | [0.8](/filings/0001144204-19-038523.md) | [2.6](/filings/0001104659-19-061527.md) | [3.1](/filings/0001104659-20-058625.md) | [0.4](/filings/0001104659-20-058625.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities

## Cash flow

| Line item | Unit | Q2 FY2019 (2019-06-30) | Q3 FY2019 (2019-09-30) | Q4 FY2019 (2019-12-31) | Q1 FY2020 (2020-03-31) | Q2 FY2020 (2020-06-30) | Q3 FY2020 (2020-09-30) | Q4 FY2020 (2020-12-31) | Q1 FY2021 (2021-03-31) | Q2 FY2021 (2021-06-30) | Q3 FY2021 (2021-09-30) | Q4 FY2021 (2021-12-31) | Q1 FY2022 (2022-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(16.3) d](/filings/0001104659-20-091993.md) | [(11.4) d](/filings/0001104659-20-122361.md) | [(0.1) d](/filings/0001410578-22-000220.md) | [(45.7)](/filings/0001104659-21-062892.md) | [(4.7) d](/filings/0001104659-21-101306.md) | [12.2 d](/filings/0001104659-21-134870.md) | [11.6 d](/filings/0001410578-22-000220.md) | [21.0](/filings/0001410578-22-001160.md) | [33.6 d](/filings/0001104659-21-101306.md) | [(4.9) d](/filings/0001104659-21-134870.md) | [23.8 d](/filings/0001410578-22-000220.md) | [65.6](/filings/0001410578-22-001160.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities

Shares outstanding: 28,000,000 at 2026-02-23, from the cover of the [10-K filed 2026-02-27](/filings/0001104659-26-021525.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:40 ET. No prices; not investment advice.